Protein level may predict immunotherapy success in four cancers
Knowledge-focused
Recruiting now
This study is for people with kidney, bladder, lung, or liver cancer who are about to start immunotherapy (PD-1/PDL-1 inhibitors). Researchers want to see if levels of a protein called Galectin-3 in the blood are linked to how well the treatment works and what side effects occur.…
Sponsor: Daniel Keizman • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC